EPHB4 and breast carcinoma: EphB6 signaling, known to suppress breast cancer cell aggressiveness by interacting with EPHB4 and interfering with EPHB4 action [49], was repressed by Pparγ1 in ErbB2 mammary tumors (Figure 2F).